John McKnight

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

Shona Livingstone, Daniel L. Levin, Helen C. Looker et al. · JAMA · 2015 · 594 citations · Full text

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

Stuart J. McGurnaghan, Amanda Weir, Jen Bishop et al. · The Lancet Diabetes & Endocrinology · 2020 · 340 citations · Full text

Preventive Medicine, Cardiovascular Epidemiology, Diabetes Epidemiology +12

Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

John McKnight, Sarah H. Wild, Maxine Lamb et al. · Diabetic Medicine · 2014 · 339 citations · Full text

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 337 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +7